The MYCOFAST® RevolutioN ATB+ is an accurate and easy-to-use colorimetric assay designed for the detection, enumeration, identification and antibiotic susceptibility determination of Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) from urogenital specimens. The MYCOFAST® RevolutioN ATB+ enables labs to determine susceptibility to a panel of new antibiotics, helping physicians comply with the latest therapeutic guidelines from CLSI (Clinical Laboratories Standards Institute). The addition of the MYCOFAST® RevolutioN ATB+ expands ELITechGroup’s family of mycoplasma test solutions, offering extensive antibiotic susceptibility determination at key clinical end-points.
Extended panel of antibiotics tested, in full compliance with worldwide recommendations
Complete diagnosis in an all-in-1 product
The right pathologic threshold tested for each specimen type
Fast results for clinicians
Visual, colorimetric reading
Featuring ready-to-use reagents and an “all liquid” method, MYCOFAST® RevolutioN ATB+ identifies the growth of U.u. and M.h. after 24 hours of incubation. Our exclusive growth activator, the M.h. Supplement, guarantees fast and accurate results. Moreover, MYCOFAST® RevolutioN ATB+ enables the enumeration of U.u. > 103 CCU/mL which is compliant with pathological thresholds recognized for sperm and urine samples. Finally, the UMMt RevolutioN & UMMt RevolutioN AMIES transport media enable optimized sample management by preserving specimen integrity up to 72 hours.
Benefits
Intended use
Mycoplasmas are the smallest and simplest of the procaryotypes capable of self-reproduction (0.15 to 0.25 μm).